Sarah Riley, NP
Adult Health · Baltimore, MDNPI 1902260920
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (45.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. Bridgebio Pharma, Inc. accounts for 81.0% of it on its own, with 11 other manufacturers making up the rest. 2025 is the largest year on record at $19,814, more than ten times the $21 reported in 2021. Among adult health clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $197.80 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bridgebio Pharma, Inc.$20K
- Merck$3K
- Scpharmaceuticals Inc.$491
- AstraZeneca$139
- Irhythm Technologies, Inc.$131
- Boehringer Ingelheim$125
- plus $291 from 6 others
What the payments were for
- Consulting fees$3,57015%
- Speaking & faculty fees$11,02546%
- Travel & lodging$6,27126%
- Food & beverage$3,25213%
- Education$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bridgebio Pharma, Inc. | 72 | $19,535 |
| Merck | 9 | $3,420 |
| Scpharmaceuticals Inc. | 21 | $491 |
| AstraZeneca | 6 | $139 |
| Irhythm Technologies, Inc. | 2 | $131 |
| Boehringer Ingelheim | 1 | $125 |
| Novartis | 4 | $99 |
| Pfizer | 2 | $52 |
| Alnylam Pharmaceuticals Inc. | 1 | $44 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $44 |
| Invivyd Inc | 1 | $29 |
| Bayer | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Attruby$18,528
- VERQUVO$990
- JARDIANCE$125
- FUROSCIX$121
- Zio monitor$106
- ZIO XT Patch$106
How this compares
$24,132 in reported general payments places this provider in the 95th percentile of 542 adult health providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EntrestoSacubitril/Valsartan | 136 | $175,889 |
| JardianceEmpagliflozin | 104 | $131,002 |
| FarxigaDapagliflozin Propanediol | 33 | $32,816 |
| MounjaroTirzepatide | 12 | $11,966 |
| Torsemide | 104 | $4,869 |
| Bumetanide | 18 | $1,648 |
| Metoprolol Succinate | 81 | $1,319 |
| Spironolactone | 131 | $1,148 |
| Potassium Chloride | 37 | $963 |
| Furosemide | 98 | $878 |
| Nifedipine ErNifedipine | 21 | $767 |
| Carvedilol | 49 | $752 |
| Losartan Potassium | 21 | $377 |
| Metolazone | 12 | $46 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| NovartisEntresto | $99 | $175,889136 claims |
| Boehringer IngelheimJardiance | $125 | $131,002104 claims |
| AstraZenecaFarxiga | $139 | $32,81633 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 542 adult health providers in Maryland.
Other adult health in Baltimore
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Brendon BowerBaltimore$64K
- Caitlin NassBaltimore$46K
- Monica LovinsBaltimore$18K
- Elizabeth ChandlerBaltimore$17K
- Clifton DawsonBaltimore$14K
- Selina YeasminBaltimore$8K
- Andrea ArroyoBaltimore$8K
- Kathleen CostelloBaltimore$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.